Enyedy Mark J
Insider CIK 1586965 · BMRN Director · CRL Director · KERX Director · FATE Director · AKBA Director · LOGC Director · IMGN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-06-02 | 2026-06-04 | 7,490 | — | $0 | 21,040 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2026-05-08 | 2026-05-11 | 1,438 | $177.62 | $255.4K | 2,384 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2025-06-02 | 2025-06-04 | 2,082 | $135.04 | $281.2K | 2,082 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2025-06-02 | 2025-06-04 | 946 | $135.04 | $127.7K | 946 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-05-20 | 2025-05-22 | 6,650 | — | $0 | 13,550 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-05-21 | 2024-05-23 | 4,720 | — | $0 | 6,900 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 925,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 922,400 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 1,100,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 1,100,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 196,875 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 140,357 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 102,466 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer | 2024-02-12 | 2024-02-12 | 584,397 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | S Sale | 2024-02-05 | 2024-02-06 | 20,107 | $29.28 | $588.7K | 584,397 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2024-02-02 | 2024-02-06 | 51,234 | — | $0 | 102,466 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2024-02-02 | 2024-02-06 | 51,234 | — | $0 | 604,504 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 140,357 | — | $0 | 140,357 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-12-27 | 2023-12-28 | 2,180 | — | $0 | 2,180 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-08-04 | 2023-08-04 | 300,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-08-04 | 2023-08-04 | 782,240 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-08-04 | 2023-08-04 | 21,978 | — | $0 | 196,875 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-08-04 | 2023-08-04 | 300,000 | $5.65 | $1.70M | 1,545,667 | SEC↗ |
| IMGN ImmunoGen, Inc. | S Sale | 2023-08-04 | 2023-08-04 | 992,397 | $16.96 | $16.83M | 553,270 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-08-04 | 2023-08-04 | 21,978 | $4.55 | $100.0K | 1,245,667 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-08-04 | 2023-08-04 | 782,240 | $5.25 | $4.11M | 1,223,689 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-08-03 | 2023-08-04 | 2,760 | — | $0 | 782,240 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-08-03 | 2023-08-04 | 186,093 | — | $0 | 196,875 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-08-03 | 2023-08-04 | 831,147 | — | $0 | 218,853 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-08-03 | 2023-08-04 | 2,760 | $5.25 | $14.5K | 444,209 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-08-03 | 2023-08-04 | 1,017,240 | $4.55 | $4.63M | 1,461,449 | SEC↗ |
| IMGN ImmunoGen, Inc. | S Sale | 2023-08-03 | 2023-08-04 | 1,020,000 | $16.61 | $16.94M | 441,449 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 995,157 | — | $0 | 382,968 | SEC↗ |
| IMGN ImmunoGen, Inc. | S Sale | 2023-08-02 | 2023-08-04 | 8,636 | $18.15 | $156.7K | 441,449 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-08-02 | 2023-08-04 | 995,157 | $4.55 | $4.53M | 1,436,606 | SEC↗ |
| IMGN ImmunoGen, Inc. | S Sale | 2023-08-02 | 2023-08-04 | 986,521 | $17.45 | $17.21M | 450,085 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-06-30 | 2023-07-05 | 5,241 | $4.05 | $21.2K | 441,449 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-02-03 | 2023-02-07 | 922,400 | — | $0 | 922,400 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-02-03 | 2023-02-07 | 153,700 | — | $0 | 153,700 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer deriv | 2022-11-16 | 2022-11-17 | 12,500 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer | 2022-11-16 | 2022-11-17 | 2,921 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-11-14 | 2022-12-27 | 787,500 | — | $0 | 1,181,250 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2022-06-30 | 2022-07-05 | 3,342 | $3.83 | $12.8K | 436,208 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2022-06-17 | 2022-06-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-05-20 | 2022-12-27 | 393,750 | — | $0 | 393,750 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 1,100,000 | $5.32 | $5.85M | 1,100,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2021-06-30 | 2021-07-02 | 3,849 | $5.52 | $21.2K | 432,866 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-02-05 | 2021-02-09 | 925,000 | $7.69 | $7.11M | 925,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | M Exercise deriv | 2021-01-01 | 2021-01-04 | 2,921 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | M Exercise | 2021-01-01 | 2021-01-04 | 2,921 | — | $0 | 2,921 | SEC↗ |
| IMGN ImmunoGen, Inc. | G Gift | 2020-12-22 | 2021-02-09 | 10,000 | — | $0 | 429,017 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2020-06-30 | 2020-07-02 | 5,241 | $3.91 | $20.5K | 439,017 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2020-06-19 | 2020-06-23 | 2,921 | — | $0 | 2,921 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-06-05 | 2020-06-09 | 13,700 | — | $0 | 31,143 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2020-03-17 | 2020-03-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | S Sale | 2020-02-24 | 2020-02-25 | 55,222 | $4.99 | $275.6K | 433,776 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-02-07 | 2020-02-11 | 1,050,000 | $4.55 | $4.78M | 1,050,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award | 2019-07-01 | 2019-07-02 | 5,230 | $1.84 | $9.6K | 488,998 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-06-06 | 2019-06-10 | 13,700 | — | $0 | 17,443 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2019-01-31 | 2019-02-04 | 785,000 | $5.25 | $4.12M | 785,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award | 2019-01-03 | 2019-01-04 | 2,455 | $4.08 | $10.0K | 534,838 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer deriv | 2018-12-12 | 2018-12-13 | 80,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 11,229 | — | $0 | 11,229 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 18,716 | — | $0 | 18,716 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer | 2018-12-12 | 2018-12-13 | 10,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2018-12-12 | 2018-12-13 | 3,743 | — | $0 | 3,743 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2018-06-30 | 2018-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2018-06-30 | 2018-07-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2018-02-22 | 2019-02-25 | 51,070 | $5.60 | $286.0K | 483,768 | SEC↗ |
| IMGN IMMUNOGEN INC | S Sale | 2018-02-21 | 2018-02-23 | 67,717 | $10.87 | $736.1K | 532,383 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-02-15 | 2018-02-20 | 1,100,000 | $10.65 | $11.71M | 1,100,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2017-09-11 | 2017-09-13 | 50,000 | $7.32 | $366.0K | 50,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2017-05-02 | 2017-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award | 2017-02-21 | 2017-02-23 | 500,000 | $2.47 | $1.24M | 600,100 | SEC↗ |
| IMGN IMMUNOGEN INC | P Buy | 2016-11-08 | 2016-11-09 | 25,000 | $1.83 | $45.8K | 100,100 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2016-05-11 | 2016-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2015-05-13 | 2015-05-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2014-06-06 | 2014-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |